IGF2BP2 is frequently overexpressed in pancreatic ductal adenocarcinoma (PDAC) and gallbladder carcinoma (GBC) and is significantly associated with poor prognosis. This evidence concerns the gene IGF2BP2 and gallbladder carcinoma.